Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin Analogues

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01585506

Enrollment

3618

Registered

2012-04-26

Start date

2010-09-20

Completion date

2010-12-20

Last updated

2018-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetes Mellitus, Type 2

Brief summary

This study is conducted in Europe. The aim of this study is to investigate psychosocial factors related to compliance with treatment with biphasic insulin analogues.

Interventions

OTHERNo treatment given

Patients to complete the WHO-5 Well-being Index questionnaire

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* Patients with type 2 diabetes in whom therapy with biphasic insulin analogues was started

Design outcomes

Primary

Measure	Time frame
Frequency and level of difficulty in introducing changes in compliance with the guidelines for biphasic insulin analogue use in subjects previously treated with biphasic human insulins	Up to 3 months

Secondary

Measure	Time frame
Correlations between the difficulty in introducing changes in compliance with the guidelines for biphasic insulin analogue use in subjects previously treated with biphasic human insulins, and psychosocial factors	Up to 3 months

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026